Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

2.2%

4 terminated/withdrawn out of 180 trials

Success Rate

95.6%

+9.0% vs industry average

Late-Stage Pipeline

33%

59 trials in Phase 3/4

Results Transparency

3%

3 of 86 completed trials have results

Key Signals

37 recruiting3 with results

Enrollment Performance

Analytics

N/A
63(47.4%)
Phase 4
52(39.1%)
Phase 2
8(6.0%)
Phase 3
7(5.3%)
Phase 1
3(2.3%)
133Total
N/A(63)
Phase 4(52)
Phase 2(8)
Phase 3(7)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (180)

Showing 20 of 180 trials
NCT07510451Not ApplicableRecruiting

The Hypotension Prediction Index Versus Standard Advanced Haemodynamic Monitoring in Patients Undergoing Major Aortic Surgery

Role: lead

NCT06789016Phase 4Completed

Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

Role: lead

NCT06470100Phase 4Completed

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty

Role: lead

NCT07157475Recruiting

Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors

Role: collaborator

NCT07478796Phase 4Recruiting

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

Role: lead

NCT07474896Not ApplicableNot Yet Recruiting

Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery

Role: lead

NCT07474909Not ApplicableNot Yet Recruiting

Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery

Role: lead

NCT07330999Not ApplicableRecruiting

Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults

Role: lead

NCT06789367Phase 4Completed

The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery

Role: lead

NCT07327931Not ApplicableRecruiting

PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults

Role: lead

NCT07023120Phase 4Completed

PENG Block Optimization: Volume and Dexamethasone Effects

Role: lead

NCT07464678Not ApplicableCompleted

Use of Platelet-Rich Fibrin (PRF) in the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ)

Role: lead

NCT07457554Not ApplicableRecruiting

Will the Use of Respiratory Quotient ''RQ'' Improve Treatment Outcomes for Intensive Care Unit (ICU) Patients?

Role: lead

NCT07449403Not ApplicableNot Yet Recruiting

SII Levels Following PENG Block in Hip Arthroplasty

Role: lead

NCT07327372Not ApplicableRecruiting

PENG Block With Dexmedetomidine in Older Adults

Role: lead

NCT07449468Not ApplicableNot Yet Recruiting

PENG Block and Delirium After Hip Arthroplasty

Role: lead

NCT07449442Not ApplicableNot Yet Recruiting

SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty

Role: lead

NCT07288983Not ApplicableRecruiting

PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery

Role: lead

NCT07245979Not ApplicableRecruiting

Supplementation With Sirtuin Activators in Women With Increased Body Weight

Role: collaborator

NCT07386600Not ApplicableRecruiting

Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA

Role: lead